Blood purification for hypercytokinemia

Riedemann, 2003, Novel strategies for the treatment of sepsis, Nat Med, 9, 517, 10.1038/nm0503-517 Cohen, 2002, The immunopathogenesis of sepsis, Nature, 420, 885, 10.1038/nature01326 Dinarello, 1997, Proinflammatory and anti-inflammatory cytokines as mediators in the pathogenesis of septic shock, Chest, 112, 321S, 10.1378/chest.112.6_Supplement.321S Dinarello, 1993, Anticytokine strategies in the treatment of the systemic inflammatory response syndrome, Jama, 269, 1829, 10.1001/jama.1993.03500140081040 Abraham, 1998, Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock NORASEPT II study group, Lancet, 351, 929, 10.1016/S0140-6736(00)80009-4 Dellinger, 2004, Surviving sepsis campaign guidelines for management of severe sepsis and septic shock, Crit Care Med, 32, 858, 10.1097/01.CCM.0000117317.18092.E4 Hirasawa, 1996, Blood purification for prevention and treatment of multiple organ failure, World J Surg, 20, 482, 10.1007/s002689900076 Bellomo, 2001, Blood purification in the intensive care unit: evolving concepts, World J Surg, 25, 677, 10.1007/s002680020030 Oda, 2002, Continuous hemofiltration/hemodiafiltration in critical care, Ther Apher, 6, 193, 10.1046/j.1526-0968.2002.00431.x Kellum, 2002, The first international consensus conference on continuous renal replacement therapy, Kidney Int, 62, 1855, 10.1046/j.1523-1755.2002.00613.x Hirayama, 2003, The change in renal replacement therapy on acute renal failure in a general intensive care unit in a university hospital and its clinical efficacy: a Japanese experience, Ther Apher Dial, 7, 475, 10.1046/j.1526-0968.2003.00094.x Hirasawa, 1986, Hemopurificaion in the treatment of patients with multiple organ failure, 73 Bellomo, 1991, Tumor necrosis factor clearances during veno-venous hemodiafiltration in the critically ill, ASAIO Trans, 37, M322 De Vriese, 1999, Can inflammatory cytokines be removed efficiently by continuous renal replacement therapies?, Intensive Care Med, 25, 903, 10.1007/s001340050981 Matsuda, 2001, Current topics on cytokine removal technologies, Ther Apher, 5, 306, 10.1046/j.1526-0968.2001.00361.x Ronco, 2004, Extracorporeal therapies in non-renal disease: treatment of sepsis and the peak concentration hypothesis, Blood Purif, 22, 164, 10.1159/000074937 Kellum, 2005, Application of blood purification to non-renal organ failure, Int J Artif Organs, 28, 445, 10.1177/039139880502800504 Damas, 1997, Sepsis and serum cytokine concentrations, Crit Care Med, 25, 405, 10.1097/00003246-199703000-00006 Nylen, 2001, Humoral markers of severity and prognosis of critical illness, Best Pract Res Clin Endocrinol Metab, 15, 553, 10.1053/beem.2001.0169 Guirao, 1996, Biologic control of injury and inflammation: much more than too little or too late, World J Surg, 20, 437, 10.1007/s002689900069 Dollner, 2001, Early diagnostic markers for neonatal sepsis: comparing C-reactive protein, interleukin-6, soluble tumour necrosis factor receptors and soluble adhesion molecules, J Clin Epidemiol, 54, 1251, 10.1016/S0895-4356(01)00400-0 Barriere, 1995, An overview of mortality risk prediction in sepsis, Crit Care Med, 23, 376, 10.1097/00003246-199502000-00026 Geppert, 2002, Multiple organ failure in patients with cardiogenic shock is associated with high plasma levels of interleukin-6, Crit Care Med, 30, 1987, 10.1097/00003246-200209000-00007 Oda, 2005, Sequential measurement of IL-6 blood levels in patients with systemic inflammatory response syndrome (SIRS)/sepsis, Cytokine, 29, 169, 10.1016/j.cyto.2004.10.010 Oberholzer, 2005, Plasma cytokine measurements augment prognostic scores as indicators of outcome in patients with severe sepsis, Shock, 23, 488 Kishimoto, 2005, Interleukin-6: from basic science to medicine – 40 years in immunology, Annu Rev Immunol, 23, 1, 10.1146/annurev.immunol.23.021704.115806 Kellum, 2002, Blood purification in sepsis: an idea whose time has come?, Crit Care Med, 30, 1387, 10.1097/00003246-200206000-00047 Fujimori, 1998, Adsorption of complement, cytokines, and proteins by different dialysis membrane materials: evaluation by confocal laser scanning fluorescence microscopy, Artif Organs, 22, 1014, 10.1046/j.1525-1594.1998.06083.x Bottoms, 1996, Efficacy of convective removal of plasma mediators of endotoxic shock by continuous veno-venous hemofiltration, Shock, 5, 149, 10.1097/00024382-199602000-00011 Hirasawa, 2000, Endotoxin adsorption or hemodiafiltration in the treatment of multiple organ failure, Curr Opin Crit Care, 6, 421, 10.1097/00075198-200012000-00009 De Vriese, 1999, Cytokine removal during continuous hemofiltration in septic patients, J Am Soc Nephrol, 10, 846, 10.1681/ASN.V104846 Swinford, 1997, Dialysis membrane adsorption during CRRT, Am J Kidney Dis, 30, S32, 10.1016/S0272-6386(97)90540-0 Cole, 2004, Cytokine removal during continuous renal replacement therapy: an ex vivo comparison of convection and diffusion, Int J Artif Organs, 27, 388, 10.1177/039139880402700507 Grootendorst, 1992, High volume hemofiltration improves hemodynamics of endotoxin-induced shock in the pig, J Crit Care, 7, 67, 10.1016/0883-9441(92)90031-2 Ronco, 2000, Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial, Lancet, 356, 26, 10.1016/S0140-6736(00)02430-2 Honore, 2000, Prospective evaluation of short-term, high-volume isovolemic hemofiltration on the hemodynamic course and outcome in patients with intractable circulatory failure resulting from septic shock, Crit Care Med, 28, 3581, 10.1097/00003246-200011000-00001 Bellomo, 2000, The effect of intensive plasma water exchange by hemofiltration on hemodynamics and soluble mediators in canine endotoxemia, Am J Respir Crit Care Med, 161, 1429, 10.1164/ajrccm.161.5.9809127 Uchino, 2002, Cytokine removal with a large pore cellulose triacetate filter: an ex vivo study, Int J Artif Organs, 25, 27, 10.1177/039139880202500105 Lee, 2004, Super high flux hemodialysis at high dialysate flows: an ex vivo assessment, Int J Artif Organs, 27, 24, 10.1177/039139880402700106 Morgera, 2004, Renal replacement therapy with high-cutoff hemofilters: impact of convection and diffusion on cytokine clearances and protein status, Am J Kidney Dis, 43, 444, 10.1053/j.ajkd.2003.11.006 Sadahiro, 2001, Usefulness of plasma exchange plus continuous hemodiafiltration to reduce adverse effects associated with plasma exchange in patients with acute liver failure, Crit Care Med, 29, 1386, 10.1097/00003246-200107000-00014 Shiga, 2004, Continuous hemodiafiltration in pediatric critical care patients, Ther Apher Dial, 8, 390, 10.1111/j.1526-0968.2004.00174.x Hirano, 2004, Modulation of polymorphonuclear leukocyte apoptosis in the critically ill by removal of cytokines with continuous hemodiafiltration, Blood Purif, 22, 188, 10.1159/000076852 Oda, 2005, Management of intra-abdominal hypertension in patients with severe acute pancreatitis with continuous hemodiafiltration using a polymethyl methacrylate membrane hemofilter, Ther Apher Dial, 9, 355, 10.1111/j.1744-9987.2005.00297.x Nakae, 1999, The effective removal of proinflammatory cytokines by continuous hemofiltration with a polymethylmethacrylate membrane following severe burn injury: report of three cases, Surg Today, 29, 762, 10.1007/BF02482322 Oberholzer, 2001, Apoptosis in sepsis: a new target for therapeutic exploration, Faseb J, 15, 879, 10.1096/fj.00-058rev Makhija, 2002, Cytokine storm in acute pancreatitis, J Hepatobiliary Pancreat Surg, 9, 401, 10.1007/s005340200049 Moriguchi, 2002, A patient with severe acute pancreatitis successfully treated with a new critical care procedure, Ther Apher, 6, 221, 10.1046/j.1526-0968.2002.00435.x Mahmoud, 2005, Effect of modified ultrafiltration on pulmonary function after cardiopulmonary bypass, Chest, 128, 3447, 10.1378/chest.128.5.3447 Hiramatsu, 2002, Effects of dilutional and modified ultrafiltration in plasma endothelin-1 and pulmonary vascular resistance after the Fontan procedure, Ann Thorac Surg, 73, 861, 10.1016/S0003-4975(01)03564-0 Chew, 2002, Effect of modified ultrafiltration on the inflammatory response in paediatric open-heart surgery: a prospective, randomized study, Perfusion, 17, 327, 10.1191/0267659102pf595oa Song, 2004, Cytokine removal with a novel adsorbent polymer, Blood Purif, 22, 428, 10.1159/000080235 Kellum, 2004, Hemoadsorption removes tumor necrosis factor, interleukin-6, and interleukin-10, reduces nuclear factor-κB DNA binding, and improves short-term survival in lethal endotoxemia, Crit Care Med, 32, 801, 10.1097/01.CCM.0000114997.39857.69 Tsuchida, 2002, Direct hemoperfusion by using Lixelle column for the treatment of systemic inflammatory response syndrome, Int J Mol Med, 10, 485 Nakatani, 2003, Effects of direct hemoperfusion with a β2-microglobulin adsorption column on hypercytokinemia in rats, Blood Purif, 21, 145, 10.1159/000069152 Oda, 2004, Cytokine adsorptive property of various adsorbents in immunoadsorption columns and a newly developed adsorbent: an in vitro study, Blood Purif, 22, 530, 10.1159/000082526 Takeda, 2003, Toll-like receptors, Annu Rev Immunol, 21, 335, 10.1146/annurev.immunol.21.120601.141126 Ullrich, 2001, A new endotoxin adsorber: first clinical application, Ther Apher, 5, 326, 10.1046/j.1526-0968.2001.00389.x Reinhart, 2004, Open randomized phase II trial of an extracorporeal endotoxin adsorber in suspected Gram-negative sepsis, Crit Care Med, 32, 1662, 10.1097/01.CCM.0000132902.54925.B5 Tani, 2001, Correlation between plasma endotoxin, plasma cytokines, and plasminogen activator inhibitor-1 activities in septic patients, World J Surg, 25, 660, 10.1007/s002680020028 Vincent, 2005, A pilot-controlled study of a polymyxin B-immobilized hemoperfusion cartridge in patients with severe sepsis secondary to intra abdominal infection, Shock, 23, 400, 10.1097/01.shk.0000159930.87737.8a Matsuno, 2001, Changes of cytokines in direct endotoxin adsorption treatment on postoperative multiple organ failure, Ther Apher, 5, 36, 10.1046/j.1526-0968.2001.005001036.x Tani, 2000, Review of endotoxin-adsorbing direct hemoperfusion therapy using a column containing polymyxin B immobilized fiber, Curr Opin Crit Care, 6, 416, 10.1097/00075198-200012000-00008 Blessing, 2004, Heparin-mediated extracorporeal low-density lipoprotein precipitation: rationale for a specific adjuvant therapy in cardiovascular disease, Transfus Apher Sci, 30, 255, 10.1016/j.transci.2004.01.009 Bengsch, 2005, Extracorporeal plasma treatment for the removal of endotoxin in patients with sepsis: clinical results of a pilot study, Shock, 23, 494 Cohen, 2000, The detection and interpretation of endotoxaemia, Intensive Care Med, 26, S51, 10.1007/s001340051119 Venet, 2000, Endotoxaemia in patients with severe sepsis or septic shock, Intensive Care Med, 26, 538, 10.1007/s001340051201 Reeves, 2002, A review of plasma exchange in sepsis, Blood Purif, 20, 282, 10.1159/000047021 Cuhaci, 2003, Plasma exchange in multiple organ failure: changing gears in sepsis and organ failure, Crit Care Med, 31, 1875, 10.1097/01.CCM.0000063052.93643.53 Busund, 2002, Plasmapheresis in severe sepsis and septic shock: a prospective, randomised, controlled trial, Intensive Care Med, 28, 1434, 10.1007/s00134-002-1410-7 Stegmayr, 2003, Plasma exchange as rescue therapy in multiple organ failure including acute renal failure, Crit Care Med, 31, 1730, 10.1097/01.CCM.0000064742.00981.14 Hirasawa, 1997, Efficacy and limitation of apheresis therapy in critical care, Ther Apher, 1, 228, 10.1111/j.1744-9987.1997.tb00143.x Nitta, 2002, Long-term survivors with artificial liver support in fulminant hepatic failure, Ther Apher, 6, 208, 10.1046/j.1526-0968.2002.00434.x Nakanishi, 2005, Intracranial pressure monitoring in patients with fulminant hepatic failure treated with plasma exchange and continuous hemodiafiltration, Blood Purif, 23, 113, 10.1159/000083205 Golden, 2003, Therapeutic hemapheresis practitioners need to know about the treatment of thrombotic thrombocytopenic purpura, Transfus Apher Sci, 28, 215, 10.1016/S1473-0502(03)00053-3 Sadler, 2004, Recent advances in thrombotic thrombocytopenic purpura, Hematology (Am Soc Hematol Educ Program), 407, 10.1182/asheducation-2004.1.407 Ronco, 2002, A pilot study of coupled plasma filtration with adsorption in septic shock, Crit Care Med, 30, 1250, 10.1097/00003246-200206000-00015 Formica, 2003, Hemodynamic response to coupled plasmafiltration-adsorption in human septic shock, Intensive Care Med, 29, 703, 10.1007/s00134-003-1724-0 Falkenhagen, 2002, Patient safety technology for microadsorbent systems in extracorporeal blood purification, Artif Organs, 26, 84, 10.1046/j.1525-1594.2002.06884.x Ash, 2001, Treatment of systemic inflammatory response syndrome by push-pull powdered sorbent pheresis: a phase 1 clinical trial, Ther Apher, 5, 497, 10.1046/j.1526-0968.2001.00298.x Mitzner, 2001, Improvement of multiple organ functions in hepatorenal syndrome during albumin dialysis with the molecular adsorbent recirculating system, Ther Apher, 5, 417, 10.1046/j.1526-0968.2001.00388.x Khuroo, 2004, Molecular adsorbent recirculating system for acute and acute-on-chronic liver failure: a meta-analysis, Liver Transpl, 10, 1099, 10.1002/lt.20139 Isoniemi, 2005, The effect of albumin dialysis on cytokine levels in acute liver failure and need for liver transplantation, Transplant Proc, 37, 1088, 10.1016/j.transproceed.2004.11.060 Di Campli, 2005, The decrease in cytokine concentration during albumin dialysis correlates with the prognosis of patients with acute on chronic liver failure, Transplant Proc, 37, 2551, 10.1016/j.transproceed.2005.06.040 Kiechl, 2002, Toll-like receptor 4 polymorphisms and atherogenesis, N Engl J Med, 347, 185, 10.1056/NEJMoa012673 Balmain, 2003, The genetics and genomics of cancer, Nat Genet, 33, 238, 10.1038/ng1107 Holmes, 2003, Genetic polymorphisms in sepsis and septic shock: role in prognosis and potential for therapy, Chest, 124, 1103, 10.1378/chest.124.3.1103 Nakada, 2005, Influence of toll-like receptor 4, CD14, tumor necrosis factor, and interleukin-10 gene polymorphisms on clinical outcome in Japanese critically ill patients, J Surg Res, 129, 322, 10.1016/j.jss.2005.05.020 Watanabe, 2005, Extremely high interleukin-6 blood levels and outcome in the critically ill are associated with tumor necrosis factor- and interleukin-1-related gene polymorphisms, Crit Care Med, 33, 89, 10.1097/01.CCM.0000150025.79100.7D